(Q44628311)

4 December 2017

title

Apolipoprotein E epsilon4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage (English)

1 reference

4 December 2017

Jie Tang

1

1 reference

4 December 2017

Jizong Zhao

2

1 reference

4 December 2017

Yuanli Zhao

3

1 reference

4 December 2017

Shuo Wang

4

1 reference

4 December 2017

Baosheng Chen

5

1 reference

4 December 2017

Wuwei Zeng

6

1 reference

4 December 2017

publication date

1 November 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

60

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

391-6; discussion 396-7

1 reference

ApoE genotype and survival from intracerebral haemorrhage

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Apolipoprotein e genotype and outcome in aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Influence of cholesterol on survival after stroke: retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Surgical risk as related to time of intervention in the repair of intracranial aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Assessment of outcome after severe brain damage

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Effect of apolipoprotein E genotype on hematoma volume after trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

APOE epsilon4 allele and amyloid beta-protein deposition in long term survivors of head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Neurodegeneration in the central nervous system of apoE-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

The apolipoprotein E epsilon4 allele and outcome in cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Prospective study of apolipoprotein E genotype and functional outcome following ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Association of apolipoprotein E polymorphism with outcome after aneurysmal subarachnoid hemorrhage: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Isoform-specific vasoconstriction induced by apolipoprotein E and modulation of this effect by Alzheimer's beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Apolipoprotein E alleles as risk factors in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Newer risk factors for stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

ApoE as a prognostic factor for post–traumatic coma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Association of apolipoprotein E polymorphism with outcome after head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Do changes in cardiovascular risk factors explain changes in mortality from stroke in Finland?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Better outcome after stroke with higher serum cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900323-9

7 January 2021

10.1016/S0090-3019(03)00323-9

Identifiers

DOI

1 reference

4 December 2017

1 reference